Woodline Partners LP Pmv Pharmaceuticals, Inc. Transaction History

Woodline Partners LP

$11 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.23 - $6.6 $861,999 - $4.63 Million	700,813 Added 64.25%	1,791,553 $5.55 Million
Q3 2023 Nov 14, 2023	BUY	$6.01 - $8.93 $2.15 Million - $3.19 Million	357,005 Added 48.66%	1,090,740 $6.7 Million
Q2 2023 Aug 14, 2023	BUY	$3.94 - $6.27 $2.2 Million - $3.5 Million	557,847 Added 317.16%	733,735 $4.59 Million
Q1 2023 May 15, 2023	SELL	$4.77 - $9.16 $3.97 Million - $7.63 Million	-832,799 Reduced 82.56%	175,888 $838,000
Q4 2022 Feb 14, 2023	BUY	$8.17 - $12.95 $893,634 - $1.42 Million	109,380 Added 12.16%	1,008,687 $8.78 Million
Q3 2022 Nov 14, 2022	BUY	$11.4 - $17.18 $4.9 Million - $7.38 Million	429,424 Added 91.39%	899,307 $10.7 Million
Q2 2022 Aug 15, 2022	SELL	$9.23 - $22.43 $2.29 Million - $5.57 Million	-248,210 Reduced 34.57%	469,883 $6.7 Million
Q1 2022 May 16, 2022	BUY	$14.86 - $23.55 $6.23 Million - $9.88 Million	419,483 Added 140.48%	718,093 $15 Million
Q4 2021 Feb 14, 2022	SELL	$19.99 - $30.24 $2.17 Million - $3.29 Million	-108,755 Reduced 26.7%	298,610 $6.9 Million
Q3 2021 Nov 15, 2021	BUY	$26.84 - $36.58 $4.52 Million - $6.16 Million	168,284 Added 70.39%	407,365 $12.1 Million
Q2 2021 Aug 16, 2021	BUY	$28.01 - $36.01 $431,101 - $554,229	15,391 Added 6.88%	239,081 $8.17 Million
Q1 2021 May 17, 2021	SELL	$30.66 - $49.5 $34,676 - $55,984	-1,131 Reduced 0.5%	223,690 $7.36 Million
Q4 2020 Feb 16, 2021	BUY	$31.86 - $61.51 $554,364 - $1.07 Million	17,400 Added 8.39%	224,821 $13.8 Million
Q3 2020 Nov 16, 2020	BUY	$35.5 - $38.0 $7.36 Million - $7.88 Million	207,421 New	207,421 $7.36 Million

Others Institutions Holding PMVP

# of Institutions

Shares Held

41.9M

Call Options Held

3.1K

Put Options Held

1.7K

Orbimed Advisors LLC San Diego, CA

6.48M
Shares

$10.4 Million
0.23% of portfolio
Arrow Mark Colorado Holdings LLC Denver, CO

3.65M
Shares

$5.87 Million
0.08% of portfolio
Sio Capital Management, LLC New York, NY

3.21M
Shares

$5.17 Million
2.53% of portfolio
Euclidean Capital LLC New York, NY

2.63M
Shares

$4.23 Million
0.43% of portfolio
Alkeon Capital Management LLC New York, NY

2.34M
Shares

$3.77 Million
0.01% of portfolio

View Full List

About PMV Pharmaceuticals, Inc.

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

More about PMVP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account